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Phosphatidylinositol 4-Phosphate 5-Kinase a Is
a Downstream Effector of the Small G Protein ARF6
in Membrane Ruffle Formation
1984), and inositol 1,4,5-trisphosphate, which mobilizes
intracellular Ca21 (Berridge and Irvine, 1984). PI(4,5)P2
is also metabolized by phosphoinositide 3-kinases to
phosphatidylinositol 3,4,5-trisphosphate (Auger et al.,
1989; reviewed by Cantley et al., 1991), which plays
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In mammalian cells, PI(4,5)P2 is synthesized through
phosphorylation of phosphatidylinositol 4-phosphate
Summary [PI(4)P] by PI(4)P 5-kinases [PI(4)P5Ks] at the D-5 posi-
tion of the inositol ring (reviewed by Toker, 1998). Type
Synthesis of phosphatidylinositol 4,5-bisphosphate I and type II of PI(4)P5Ks were initially defined (Loijens
[PI(4,5)P2], a signaling phospholipid, is primarily car- et al., 1996) and consisted of three isoforms of type
ried out by phosphatidylinositol 4-phosphate 5-kinase I, a, b, and g (Ishihara et al., 1996, 1998; Loijens and
[PI(4)P5K], which has been reported to be regulated Anderson, 1996), and three isoforms of type II (Boronen-
by RhoA and Rac1. Unexpectedly, we find that the kov and Anderson, 1995; Divecha et al., 1995; Castellino
GTPgS-dependent activator of PI(4)P5Ka is the small et al., 1997; Itoh et al., 1998). Reinvestigation of the
G protein ADP-ribosylation factor (ARF) and that the substrate specificity of PI(4)P5Ks by Rameh et al. (1997),
activation strictly requires phosphatidic acid, the prod- however, revealed that the type II PI(4)P5Ks catalyze
uct of phospholipase D (PLD). In vivo, ARF6, but not phosphorylation of a novel phosphoinositide phosphati-
ARF1 or ARF5, spatially coincides with PI(4)P5Ka. This dylinositol 5-phosphate at the D-4 position of the inositol
colocalization occurs in ruffling membranes formed ring, leading to the revised conclusion that the type II
upon AlF4 and EGF stimulation and is blocked by domi- enzymes are actually phosphatidylinositol 5-phosphate
nant-negative ARF6. PLD2 similarly translocates to the 4-kinases. Thus, the PI(4)P5K family now comprises just
ruffles, as does the PH domain of phospholipase Cd1, the three isoforms, a, b, and g.
indicating locally elevated PI(4,5)P2. Thus, PI(4)P5Ka PI(4)P5K has been reported to be activated in vitro
by acid phospholipidsÐspecifically phosphatidic acidis a downstream effector of ARF6 and when ARF6 is
(PA) (Moritz et al., 1992; Jenkins et al., 1994; Ishihara etactivated by agonist stimulation, it triggers recruit-
al., 1996, 1998) and phosphatidylserine (PS) (Cochet andment of a diverse but interactive set of signaling mole-
Chambaz, 1986). PI(4)P5K was also anticipated to becules into sites of active cytoskeletal and membrane
regulated by a GTP-binding protein, based on the findingrearrangement.
that GTPgS stimulates PI(4,5)P2 production in human
placenta, rat brain, and rat liver membranes (UrumowIntroduction
and Wieland, 1986; Smith and Chang, 1989; Urumow
and Wieland, 1990). Chong et al. (1994) and Hartwig et
Phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] plays al. (1995) reported that the small G proteins RhoA and
crucial roles in various cellular signaling pathways. One
Rac1 respectively stimulate PI(4,5)P2 production in ly-of the best understood of its functions is to serve as a sates from mouse fibroblasts and in permeabilized
precursor of two well-characterized second messengers platelets, which suggested that they are direct activators
produced by phospholipase C (Berridge, 1987): diacyl- of PI(4)P5K. However, such direct activation has never
glycerol, which activates protein kinase C (Nishizuka, actually been formally demonstrated.
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Figure 1. Effects of GTPgS and PA on
PI(4,5)P2 Production in Bovine Brain Cytosol
(A) Bovine brain cytosol was incubated alone
(open columns), with 40 mM of GTPgS (stip-
pled columns), with 50 mM PA (hatched col-
umns), or with both (solid columns), in the
absence (left four columns) or presence (right
four columns) of 0.2 M ammonium sulfate,
following which the amounts of [32P]PI(4,5)P2
generated were determined as described in
Experimental Procedures. The upper panel
shows an autoradiogram of the [32P]PI(4,5)P2
produced, which was separated by TLC.
(B) Bovine brain cytosol was incubated alone
(open circles) or with 40 mM of GTPgS (closed
circles) in the presence of the indicated con-
centrations of PA and of 0.2 M ammonium
sulfate as above.
(C) Vehicle (left four columns) or the COS-7 cell-expressed recombinant mouse PI(4)P5Ka (right four columns) was added to bovine brain
cytosol, which was then assayed in the presence of 0.2 M ammonium sulfate as in (A).
The results shown in (A), and (B) and (C) are from a single experiment in single and duplicate, respectively, representative of five performed.
The error bars represent the differences of duplicate determinations.
through its product PI(4,5)P2, it is likely to play a role GTPgS-dependent activator of PI(4)P5Ka that functions
only in the presence of PA exists in bovine brain cytosol.in membrane ruffle formation as induced by epidermal
growth factor (EGF).
Purification and Identification of a GTPgS-Dependent
PI(4)P5Ka ActivatorResults
By assaying recombinant mouse PI(4)P5Ka in combina-
tion with bovine brain cytosol sequentially fractionatedGTPgS and PA Synergistically Increase PI(4,5)P2 by column chromatographies, a GTPgS-dependent acti-Production in Bovine Brain Cytosol
vator of PI(4)P5Ka was purified (Figures 2A±2E). On theWe began our studies by reexamining the requirements
final Superdex 75 HR 10/30 column, the activator elutedfor PI(4)P5K activation, since the stimulation of PI(4,5)P2 in a single peak as a 21 kDa protein (Figure 2E) andproduction by PA and PS had been assessed using
SDS-PAGE analysis (Figure 2F) revealed that it had beencytosol or recombinant PI(4)P5Ks (Cochet and Cham-
purified to near homogeneity. The purification was aboutbaz, 1986; Moritz et al., 1992; Jenkins et al., 1994; Ishi-
400-fold with 2.4% yield (data not shown), implying thathara et al., 1996, 1998), while the stimulation by GTPgS
the activator is abundant in bovine brain cytosol.had been demonstrated using membrane preparations
To identify the activator, amino acid sequences of(Urumow and Wieland, 1986; Smith and Chang, 1989;
trypsin-digested peptide fragments of the purified pro-Urumow and Wieland, 1990). Unexpectedly, although
tein were analyzed. The sequences of the six peptideaddition of PA to bovine brain cytosol increased PI(4,5)P2 fragments analyzed exhibited identity to the small Gproduction by 2- to 3-fold, significant stimulation by
proteins ARF1 and ARF3, which are identical over theGTPgS alone was not observed (Figure 1A). However,
regions covered by the peptide sequences (Figure 3A).GTPgS did strongly increase PI(4,5)P2 production when The 21 kDa protein eluted from the Superdex 75 HRPA was present. In the presence of 0.2 M ammonium
10/30 column was strongly recognized by an anti-ARFsulfate, similar effects of GTPgS and/or PA were ob-
antibody in parallel with the PI(4)P5Ka activation (Figureserved, but the basal level was lower and therefore the
3B). In contrast, anti-RhoA, anti-Rac1, and anti-Cdc42relative stimulation much greater. This appeared to be
antibodies failed to react with the protein (Figure 3C).due to inhibition of enzymes that were further metaboliz-
These results demonstrated that ARF is the most abun-ing PI(4,5)P2 produced (data not shown). Accordingly, dant GTPgS-dependent activator of PI(4)P5Ka in brainammonium sulfate was thereafter included in the crude
cytosol.assay system. The extent of increase in PI(4,5)P2 produc-
tion by GTPgS was critically dependent upon the pres-
ence of PA (Figure 1B). Thus, GTPgS absolutely required Reconstitution of Synergistic Activation of PI(4)P5Ka
by PA and ARF, but Not by RhoA, Rac1,the presence of PA to stimulate PI(4,5)P2 production in
bovine brain cytosol, and in combination the two stimu- and Other Phospholipids
When bacterial recombinant PI(4)P5Ka and myristoy-lators were synergistic.
The increase in PI(4,5)P2 production by GTPgS and lated ARF1 (myr-ARF1) were combined in the presence
of PA (Figure 4A), myr-ARF1 activated the enzyme inPA appeared to be, at least in part, attributable to the
activation of PI(4)P5Ka, inasmuch as a similar but aug- the presence of GTPgS, but not GDP, and in a concentra-
tion-dependent manner, although the concentrations ofmented response was observed when recombinant
mouse PI(4)P5Ka was added to the cytosol (Figure 1C). myr-ARF1 required were higher than those for the native
protein. Nonetheless, the results provide evidence thatThese results, taken together, demonstrated that a
PI(4)P5Ka as a Downstream Effector of ARF6
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Figure 2. Purification of a GTPgS-Dependent
Activator of PI(4)P5Ka from Bovine Brain Cy-
tosol
Bovine brain cytosol proteins were precipi-
tated with ammonium sulfate at 25%±60%
saturation and subjected to sequential chro-
matography on DEAE Sephacel (A), Sepha-
cryl S-300 HR (B), Hydroxyapatite (C), Phenyl-
TOYOPEARL 650M (D), and Superdex 75 HR
10/30 columns (E). Each column fraction
was assessed for activation of COS-7 cell-
expressed recombinant mouse PI(4)P5Ka in
the presence of 0.2 M ammonium sulfate, 40
mM GTPgS, and 50 mM PA as in Figure 1.
Fractions eluted from the Superdex 75 HR
10/30 column were additionally analyzed by
SDS-PAGE/CBB staining (F). The results shown
are from a single experiment representative
of three performed with independent prepa-
rations of bovine brain cytosol.
the activation by ARF1 of PI(4)P5Ka is attributable to instead of ARF since PA did not affect [35S]GTPgS bind-
ing to ARF1 (Figure 4E) and PI(4)P5Ka activity was pref-their direct interaction. ARF5 and ARF6, class II and III
ARFs, respectively, also activated PI(4)P5Ka (Figure 4B). erentially precipitated by phospholipid vesicles con-
taining PA (Figure 4F).The identification of ARF as the primary endogenous
activator of PI(4)P5K was surprising because RhoA and
Rac1 had been previously implicated in this role (Chong
et al., 1994; Hartwig et al., 1995). To investigate whether ARF6-Dependent Translocation of PI(4)P5Ka
to Ruffling Membranes with ConcomitantPI(4)P5Ka is also activated by these small G proteins,
the ability of recombinant RhoA and Rac1 purified from PI(4,5)P2 Formation and Cotranslocation
of PLD2Sf9 cells to stimulate bacterial recombinant PI(4)P5Ka
was compared with that of ARF1 (Figure 4C). Whereas To address which isoform of ARF is the physiological
activator of PI(4)P5Ka, subcellular localization of C-ter-ARF1 activated PI(4)P5Ka, RhoA and Rac1 were without
effect. Similar results were obtained using mammalian minally hemagglutinin (HA) epitope-tagged ARFs (ARFs-
HA) and N-terminally myc epitope-tagged PI(4)P5Karecombinant PI(4)P5Ka (data not shown). The recombi-
nant RhoA and Rac1 were clearly active, since they [myc-PI(4)P5Ka] coexpressed in HeLa cells were visual-
ized using indirect immunofluorescence microscopy,stimulated human PLD1a in the presence of GTPgS (data
not shown). These results, taken together, provide evi- under the assumption that activation will take place only
if colocalization occurs (Figure 5A). In unstimulateddence that ARF is the specific activator of PI(4)P5Ka in
vitro. cells, ARF1 was localized exclusively to perinuclear
Golgi membranes, ARF5 to the nucleus and perinuclearSince it has been reported that PS, as well as PA,
activates PI(4)P5K (Cochet and Chambaz, 1986), phos- membranes and vesicles, and ARF6 throughout the cy-
toplasm and at the plasma membrane, as reported pre-pholipid specificity in the activation of PI(4)P5Ka was
assessed (Figure 4D). Phosphatidylethanolamine (PE), viously (Hosaka et al., 1996; Radhakrishna et al., 1996).
PI(4)P5Ka localized to the plasma membrane and alsophosphatidylcholine (PC), PI, and lyso-PA (LPA) did not
significantly activate PI(4)P5Ka, which was assayed in to punctate structures dispersed throughout the cyto-
plasm. Upon stimulation by AlF4, cells overexpressingcombination with myr-ARF1, irrespective of the pres-
ence of GDP or GTPgS. Although PS, like PA, modestly ARF6 formed membrane ruffles and ARF6 became con-
centrated in the ruffles, as previously reported (Radha-activated the enzyme in the presence of GDP, it failed
to synergize with GTPgS-bound ARF1. Thus, synergistic krishna et al., 1996, 1999). Strikingly, PI(4)P5Ka cotrans-
located with ARF6 to the ruffles. Neither colocalization,activation with ARF1 was specific to PA. This PA effect
seemed to be attributable to direct action on PI(4)P5Ka membrane ruffles, nor obvious translocation of PI(4)P5Ka
Cell
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Figure 3. Identification of ARF1/ARF3 as the
GTPgS-Dependent Activator of PI(4)P5Ka
(A) The purified GTPgS-dependent activator
of PI(4)P5Ka was digested with trypsin and
the fragments obtained were purified and se-
quenced as described in Experimental Pro-
cedures. The sequences of the six fragments
determined are shown in italic type with num-
bers. Boxes represent sequences identical to
those of the purified activator. Dots represent
amino acid residues identical to the sequence
of ARF1.
(B) Proteins in fractions eluted from the
Superdex 75 HR 10/30 column were analyzed
by Western blotting using an anti-ARF an-
tibody.
(C) Proteins in the peak fraction 27 from the
Superdex 75 HR 10/30 column were blotted
with anti-ARF, anti-RhoA, anti-Rac1, and
anti-Cdc42 antibodies. The results shown are
from a single experiment representative of
three performed with independently purified
preparations of the PI(4)P5Ka activator.
upon AlF4 stimulation was observed in cells coexpress- (PH/PLCd1), which has a high affinity for PI(4,5)P2, as
a reporter to visualize PI(4,5)P2 localization in the plasmaing ARF1 or ARF5, although ARF5 appeared to become
concentrated in the nucleus. Thus, observation of both membrane (Varnai and Balla 1998; Fujii et al., 1999) (Figure
5D). Green fluorescent protein (GFP)±fused PH/PLCd1steady-state and stimulated conditions suggest that it
is ARF6 that functions as the physiological regulator of (GFP-PH/PLCd1) coexpressed with myc-PI(4)P5Ka and
ARF6 in HeLa cells localized at the plasma membranePI(4)P5Ka. This finding is not in conflict with our recovery
of cytosolic bovine brain ARF1/3 as the activator, since and in punctate structures in the cytoplasm in nonstimu-
lated control cells. Upon EGF stimulation, PH/PLCd1very little ARF6 would be present in the cytosol relative
to the ARF1 and ARF3 expression levels. To generalize translocated to the ruffling membranes formed by 7 min,
and then dispersed as the membrane ruffles disap-this for physiological agonists, EGF was employed (Fig-
ure 5B). EGF stimulation resulted in the formation of peared. The localization of PH/PLCd1 at the ruffles coin-
cided with that of PI(4)P5Ka. Moreover, the dominant-membrane ruffles to which ARF6 and PI(4)P5Ka cotrans-
located. As would be expected, actin filaments were also negative ARF6, ARF6 N122I, inhibited the EGF-induced
localization of PH/PLCd1 at the plasma membrane (dataconcentrated at the ruffles (data not shown). Membrane
ruffling was transient, readily visualized at 7 min and sub- not shown). These results suggest that the PH/PLCd1
redistribution was driven by activation of PI(4)P5Ka atsiding within 30 min, whereupon ARF6 and PI(4)P5Ka
became concomitantly redistributed. the plasma membrane and concomitant PI(4,5)P2 gener-
ation.The results above suggested that PI(4)P5Ka translo-
cation to membrane ruffles upon EGF stimulation should Although a small amount of PA exists in the steady-
state level in plasma membranes, it is better known forbe ARF6 dependent. In support of this model, cotrans-
fection of the dominant-negative, GTP binding±defec- being dynamically regulated by the action of PLD, which
generates PA through the hydrolysis of PC in responsetive ARF6 mutant, ARF6 N122I, completely inhibited the
translocation of PI(4)P5Ka and membrane ruffling for- to a wide variety of agonists (Billah, 1993), including AlF4
(Schmidt et al., 1996). Two isoforms of mammalian PLD,mation upon EGF stimulation (Figure 5C). The notion
of ARF6-dependent translocation of PI(4)P5Ka is also PLD1 and PLD2, have been molecularly identified (Ham-
mond et al., 1995, 1997; Colley et al., 1997). We soughtsupported by a recent report showing that ARF purified
from bovine brain cytosol recruits PI(4)P5K activity in to determine whether a potential source for significant
levels of PA required for PI(4)P5Ka activation might bethe cytosol to the Golgi complex in an in vitro system
(Godi et al., 1999). present in membrane ruffles (Figure 5E). HA-PLD2 coex-
pressed with myc-PI(4)P5Ka and ARF6 in HeLa cells wasTo establish that the PI(4)P5Ka translocated to the
plasma membrane is in the active state and generates localized exclusively in the cytosol and at the plasma
membrane in unstimulated cells, consistent with aPI(4,5)P2 locally, we employed the PH domain of PLCd1
PI(4)P5Ka as a Downstream Effector of ARF6
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Figure 4. Reconstitution of Synergistic Acti-
vation of PI(4)P5Ka by ARFs and PA, but Not
by RhoA, Rac1, and Other Phospholipids
(A) Recombinant PI(4)P5Ka (15 nM) and the in-
dicated concentrations of myr-ARF1 (squares),
both of which were purified from E. coli, or
purified ARF from bovine brain cytosol (cir-
cles) were combined and assayed for 25 min
at 378C with 40 mM of GDP (open symbols)
or GTPgS (closed symbols) in the presence
of 50 mM PA following which [32P]PI(4,5)P2
production was quantitated.
(B) Bacterial recombinant PI(4)P5Ka (15 nM)
was assayed in combination with vehicle or
30 nM of recombinant ARF1, ARF5, or ARF6
purified from COS-7 cells in the presence of
40 mM of GTPgS and 50 mM PA.
(C) Bacterial recombinant PI(4)P5Ka (15 nM)
was assayed in combination with vehicle or
500 nM of recombinant ARF1, RhoA, or Rac1
purified from Sf9 cells in the presence of 40
mM of GTPgS and 50 mM PA.
(D) Bacterial recombinant PI(4)P5Ka (15 nM)
was combined with myr-ARF1 (300 nM) and
assayed in the presence of 12.5 mM of the
indicated phospholipids and 40 mM of GDP
(open columns) or GTPgS (solid columns). In this experiment, the PI(4)P substrate was used at 12.5 mM.
(E) Bacterial myr-ARF1 (3 mM) was incubated for 25 min at 378C with 10 mM of [35S]GTPgS in the presence of 12.5 mM of the indicated
phospholipids. [35S]GTPgS bound to myr-ARF1 was determined as described in Experimental Procedures.
(F) Bacterial recombinant PI(4)P5Ka (15 nM) was incubated for 20 min at room temperature with 150 mM PE/20 mM PC vesicles containing
200 mM of PE (open column) or PA (solid column) in the presence of 100 mM NaCl and 5 mg/ml BSA. After centrifugation, PI(4)P5K activity
in the supernatant was determined as described in Experimental Procedures.
Shown are the results from a single experiment in duplicate and representative of five with similar results. The error bars represent the
differences of duplicate determinations.
previous report (Colley et al., 1997). With EGF stimula- the EGF-induced signaling pathway that induces ARF6-
dependent PI(4)P5Ka translocation to the plasma mem-tion, the overexpressed PLD2 translocated to the ruffling
membranes as visualized at 7 min and colocalized with brane is mediated by Rac1 and that the local production
of PI(4,5)P2 at the plasma membrane is, at least in part,PI(4)P5Ka. As before, ruffle formation was transient, and
both proteins became redistributed in parallel with con- involved in the membrane ruffling formation. Although
consistent with a previous report (Ridley et al., 1992), thecomitant retraction of the ruffles. In contrast, PLD1 did
not alter its perinuclear distribution upon EGF stimula- dominant-negative Rac1 mutant, Rac1 T17N, inhibited
EGF-induced membrane ruffling, it nonetheless failed totion (data not shown). These results demonstrate that a
mechanism to locally generate PA is established during interfere with the EGF-induced cotranslocation of ARF6
and PI(4)P5Ka to the plasma membrane and concomi-membrane ruffle formation and suggests that it plays a
role in the activation of PI(4)P5Ka. tant PI(4,5)P2 production, the latter of which was de-
tected using the anti-PI(4,5)P2 antibody (Figure 6C). In
mock transfected cells, both the membrane ruffling and
Requirement of Local Production of PI(4,5)P2 cotranslocation of ARF6 and PI(4)P5Ka to the ruffles
for Membrane Ruffling Formation
were observed (data not shown). These results, taken
Growth factor±induced membrane ruffling formation is
together, lead to the conclusion that (1) the local genera-
also regulated by the Rho family GTPase Rac1 (Ridley
tion of PI(4,5)P2 by activated PI(4)P5Ka at the plasmaet al., 1992). Radhakrishna et al. (1999) have recently
membrane is essential, but not sufficient, for membrane
reported that the dominant-negative ARF6 mutant inhib-
ruffling formation; (2) ARF6-dependent translocation
its the membrane ruffling formation induced by the con-
of PI(4)P5Ka to the plasma membrane involves Rac1-
stitutively active Rac1 mutant. Consistent with these
dependent and -independent mechanisms; and (3) in
reports, membrane ruffles were formed by the active
addition to the ARF6-dependent local production of
Rac1 mutant, Rac1 G12V, which colocalized to the ruf-
PI(4,5)P2, another Rac1-dependent, ARF6-independentfles with coexpressed ARF6 and PI(4)P5Ka, and the
pathway is required for the membrane ruffling formation
dominant-negative ARF6 mutant, ARF6 N122I, inhibited
induced by EGF stimulation, as illustrated in Figure 7.
both the membrane ruffling formation and the transloca-
tion of PI(4)P5Ka induced by Rac1 G12V (Figure 6A),
as was observed in EGF-stimulated cells (Figure 5C). Discussion
Furthermore, microinjection of an anti-PI(4,5)P2 anti-
body, AM212 (Miyazawa et al., 1988), almost completely In the present study, we demonstrate that the small G
protein ARF directly activates PI(4)P5Ka in concert withinhibited the membrane ruffling formation induced by
Rac1 G12V (Figure 6B). These observations suggest that PA. Furthermore, we provide evidence that PI(4)P5Ka
Cell
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Figure 5. ARF6-Dependent Translocation of PI(4)P5Ka to Ruffling Membranes with Concomitant PI(4,5)P2 Formation and Cotranslocation of PLD2
(A) Myc-PI(4)P5Ka was cotransfected with ARF1-HA, ARF5-HA, or ARF6-HA in HeLa cells. After 6 hr of additional culture in the presence of
5% FCS, cells were treated without or with AlF4 (30 mM sodium fluoride plus 50 mM aluminum chloride) at 378C for 30 min, and localization
of ARFs and PI(4)P5Ka was then visualized as described under Experimental Procedures.
(B) HeLa cells cotransfected with myc-PI(4)P5Ka and ARF6-HA were cultured in DMEM without FCS for 36 hr, stimulated with 10 ng/ml of
EGF at 378C for the times indicated, then processed as in (A).
(C) Wild-type ARF6-HA or the dominant-negative mutant ARF6 N122I-HA was cotransfected with myc-PI(4)P5Ka in HeLa cells. Cells were
further cultured as in (B), then stimulated with 10 ng/ml of EGF at 378C for 7 min and imaged as in (A).
(D) HeLa cells cotransfected with GFP-PH/PLCd1, myc-PI(4)P5Ka, and ARF6, were cultured and stimulated with EGF as in (B), and imaged
as in (A).
(E) HeLa cells cotransfected with HA-PLD2, myc-PI(4)P5Ka, and ARF6, were cultured and stimulated with EGF as in (B), and imaged as in (A).
Shown is one experiment representative of five performed.
PI(4)P5Ka as a Downstream Effector of ARF6
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Figure 6. Analysis for the Mechanisms by which Membrane Ruffles Are Formed
(A) Myc-Rac1 G12V was cotransfected with myc-PI(4)P5Ka and with wild type ARF6-HA or the dominant-negative mutant ARF6 N122I-HA in
HeLa cells. After culture in DMEM without FCS for 36 hr, localization of the tagged proteins was visualized as described under Experimental
Procedures.
(B) HeLa cells were transfected with Rac1 G12V, cultured 34 hr, then microinjected with 2 mg/ml of control mouse IgG or the monoclonal
anti-PI(4,5)P2 antibody (AM212). After 2 hr, actin filaments and IgG were visualized as described under Experimental Procedures.
(C) HeLa cells were transfected with Rac1 T17N (shown) or mock (not shown), cultured for 32 hr, and then microinjected with expression
vectors for ARF6 and PI(4)P5Ka. After 4 hr, cells were stimulated with 10 ng/ml of EGF at 378C for 7 min, and localization of ARF6, PI(4)P5Ka
and PI(4,5)P2 were visualized as described under Experimental Procedures.
Shown is one experiment representative of five performed.
is a downstream effector of ARF6, and that it is synergis- (Liang and Kornfeld, 1997), was considerably less effec-
tive than the native proteins (Figure 4A). Since the func-tically activated by ARF6 and the PLD2 product PA to
increase local production of PI(4,5)P2 in the plasma tion of myristoylation is to promote membrane localiza-
tion of GTP-bound ARF, this suggests, in combinationmembrane upon EGF stimulation, which in turn pro-
motes membrane ruffling formation in concert with the with the absolute requirement of the membrane lipid
Rac1-specific pathway. PA, that activation of PI(4)P5Ka takes place only at mem-
brane surfaces where activated ARF and PLD2 (as the
source for PA) coincide.Activation Mechanism of PI(4)P5K by PA and Small
G Proteins RhoA and Rac1 had been reported to activate PI(4)P5K
in mouse fibroblast lysates and permeabilized platelets,In the present study, we identified ARF as the direct
activator of PI(4)P5Ka in vitro (Figures 3 and 4). As re- respectively (Chong et al., 1994; Hartwig et al., 1995).
Under the conditions employed in this study, however,ported previously for the activation of PLD (Brown et al.,
1993; Cockcroft et al., 1994) and for promoting vesicular they failed to activate PI(4)P5Ka (Figure 4C). These re-
sults indicate that the stimulation by RhoA and Rac1 oftransport (Balch et al., 1992; Kahn et al., 1992; Lenhard
et al., 1992), myristoylation of ARF also appears to be PI(4)P5K reported must reflect an indirect mechanism.
Alternatively, RhoA and Rac1 may regulate an unidenti-required for the activation of PI(4)P5Ka, since the recom-
binant myr-ARF1, which is partially (10%±50%) myris- fied isoform of PI(4)P5K, which is supported by a pre-
vious report that RhoA physically associates with atoylated in E. coli coexpressing N-myristoyltransferase
Cell
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Relationship between Rac1 and ARF6 in the
Membrane Ruffling Signaling Pathway
Franco et al. (1999) recently identified the guanine nucle-
otide exchange factor for ARF6 (EFA6) and found that
expression of EFA6 induces membrane ruffles. Further-
more, they have demonstrated that both dominant-neg-
ative mutants of ARF6 and Rac1 inhibited the EFA6-
induced membrane ruffles. From these results, they hy-
pothesized that EFA6 activates both ARF6 and Rac1 in
parallel pathways. This hypothesis (Rac1-independent
activation of ARF6) is consistent with the results show-
ing the failure of Rac1 T17N to inhibit the ARF6-depen-
dent signaling leading to the activation of PI(4)P5Ka
(Figure 6C). In addition, ARF6 could also be activated
by a Rac1-dependent mechanism, which may involve
an ARF-GEF (Figure 7), based on the result that ARF6
N122I inhibited the Rac1 G12V-induced translocation of
PI(4)P5Ka to the plasma membrane (Figure 6A). Further-
Figure 7. Working Hypothesis for the Mechanisms of PI(4)P5Ka Ac- more, it could be speculated that membrane ruffling
tivation and of Membrane Ruffling Formation upon EGF Stimulation
formation induced by EGF requires two parallel path-
See text for details.
ways; one being the ARF6-dependent activation of
PI(4)P5Ka and the consequent PI(4,5)P2 elevation, and
the other a Rac1-specific, ARF6-independent pathway
PI(4)P5K that is insensitive to PA (Ren et al., 1996). It is possibly mediated by POR1, a Rac1-interacting protein
also conceivable that their target is the b or g isoform involved in membrane ruffling (D'Souza-Schorey et al.,
of PI(4)P5K, although unpublished data from our lab 1997) (Figure 7). This hypothesis is supported by the
suggests that this is not the case. The nature of the findings that the dominant-negative ARF6 N122I and the
PI(4)P5K that Rac1 associates with in rat liver cytosol anti-PI(4,5)P2 antibody inhibited the Rac1 G12V-inducedand Rat1a fibroblast lysates in a GTP-independent man- membrane ruffling formation (Figures 6A and 6B), while
ner (Tolias et al., 1995, 1998) remains undetermined. EGF stimulation still caused the cotranslocation of
It has been reported that GTPgS significantly activates PI(4)P5Ka and ARF6 to the plasma membrane where
PI(4)P5K in membranes (Urumow and Wieland, 1986; PI(4,5)P2 was produced, without induction of the mem-
Smith and Chang, 1989; Urumow and Wieland, 1990). brane ruffling in cells overexpressing the dominant-
We found the stimulation of PI(4,5)P2 formation by negative Rac1 T17N (Figure 6C). The observation by
GTPgS alone to be minimal, if any, in the cytosol (Figure D'souza-Schorey et al. (1997) that ARF6 and POR1 syn-
1). Since the addition of PA to the cytosol allowed GTPgS ergistically induce membrane ruffling also supports this
to stimulate PI(4,5)P2 formation (Figure 1) and GTPgS- model.
bound ARF activated PI(4)P5Ka in the presence, but not
in the absence, of PA in the reconstituted system (Figure Relationship of PLD2 to the Activation of PI(4)P5Ka
4D), the lack of the ability of GTPgS to activate PI(4)P5K Both PLD1 and PLD2 are ARF responsive (Hammond
in the cytosol is clearly attributable to the absence of et al., 1995, 1997; Sung et al., 1999a, 1999b), although
PA; in contrast, membranes constitutively contain basal the details of this regulation in vivo are not well under-
levels of PA, and therefore addition of GTPgS alone to stood. In this study, PLD2 was found to cotranslocate
them increases PI(4,5)P2 production. with PI(4)P5Ka to the ruffling membranes formed upon
The requirement of phospholipids for ARF activation EGF stimulation (Figure 5E), whereas PLD1 did not alter
of PI(4)P5Ka was specific to PA (Figure 4D). This specific its perinuclear location, suggesting that PLD2, but not
effect of PA cannot be simply explained by a physical PLD1, is involved in PI(4)P5Ka activation in this setting.
effect on the substrate vesicle structure through its neg- This conclusion is also supported by the observation
ative charge, since the other negatively charged phos- that EGF stimulation of cells overexpressing PLD2 stim-
pholipids tested, PS, PI, and LPA, were without effect. ulates PLD activity (Slaaby et al., 1998), and that overex-
It is also unlikely that PA has a direct effect on ARF, pression of PLD2 in many cell types results in actin
since PA did not affect [35S]GTPgS binding to ARF1 un- cytoskeletal rearrangements (Colley et al., 1997).
der these conditions (Figure 4E) nor is PA required for It should be noted, though, that PLD1 may activate
another ARF downstream effector, PLD (Hammond et another PI(4)P5K isoform(s) different from PI(4)P5Ka,
al., 1997). The most likely explanation is that PA directly or even PI(4)P5Ka itself in a different setting, since
stimulates PI(4)P5Ka: PI(4)P5Ka binds to phospholipid PI(4)P5Kb has been reported in association with recep-
vesicles containing PA, but not to vesicles lacking PA tor signaling and endocytosis (Davis et al., 1997), and
(Figure 4F). This notion is also supported by the fact one or more of the PI(4)P5K isoforms is involved in the
that even by itself PA stimulates PI(4)P5Ka, but it does priming of exocytosis (Hay et al., 1995), either of which
not stimulate PI(5)P4Ka (data not shown). These obser- may involve PLD1. Nevertheless, although further inves-
vations lead us to speculate that binding of PA to tigation is required to explore the involvement of PLD2
PI(4)P5Ka causes a conformational change in the en- in PI(4)P5Ka activation, this report demonstrates a novel
zyme, which in turn allows it to interact with the active physiological function for PLD2 and it sheds insight into
the role of PLD2 in EGF-stimulated cellular signaling.form of ARF, thereby leading to synergistic stimulation.
PI(4)P5Ka as a Downstream Effector of ARF6
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Rac1 G12V were generated using pcDNA3-myc, which was con-Novel Physiological Function of PI(4)P5Ka
structed by insertion of a myc epitope±encoding linker into pcDNA3.It is firmly established that regulated exocytosis, such
An HA-tagged version of PI(4)P5Ka was generated using pTB701-as ATP-dependent, Ca21-activated neurotransmitter se-
HA. The construction of plasmids for ARFs-HA, ARF6 N122I-HA,
cretion in PC12 cells (Hay et al., 1995) and enzyme re- and HA-PLD2 were previously described (Hosaka et al., 1996; Colley
lease in HL-60 cells (Fensome et al., 1996), appears et al., 1997; Toda et al., 1999). The expression vectors for GFP-
PH/PLCd1 and FLAG-Rac1 T17N were generous gifts of Dr. Yagi-to be mediated by PI(4,5)P2 produced by the action of
sawa, Himeji Institute of Technology, Japan (Fujii et al., 1999) andPI(4)P5K. In addition to this role, we provide evidence
of Dr. Kaziro, Tokyo Institute of Technology, Japan respectively.in the present study for a novel function for PI(4)P5Ka,
i.e., involvement in membrane ruffle formation as in-
Preparation of Recombinant PI(4)P5Ka, ARFs, RhoA, and Rac1duced by EGF stimulation, which also appears likely to
To prepare mammalian recombinant FLAG-PI(4)P5Ka and ARFs-
be mediated by its product PI(4,5)P2, inasmuch as the FLAG, pTB701-FLAG-PI(4)P5Ka and pcDNA3-ARFs-FLAG were
local production of PI(4,5)P2 at the ruffling membrane transfected into COS-7 cells by electroporation and the proteins
purified as previously described (Yamazaki et al., 1999).and the inhibition by the anti-PI(4,5)P2 antibody of the
FLAG-PI(4)P5Ka was also inducibly expressed in E. coli with 1Rac1 G12V-induced membrane ruffling formation were
mM isopropyl-b-D-thiogalactopyranoside (IPTG). After disruption ofobserved (Figures 5D and 6B). This idea is consistent
cells and centrifugation, the supernatant was subjected to chroma-with many reports linking PI(4,5)P2 to reorganization of tography on a Sulfate Cellulofine column (Seikagaku Co., Japan).
the actin cytoskeleton through the regulation of actin- Fractions containing FLAG-PI(4)P5Ka were further subjected to
binding proteins (Lassing and Lindberg, 1985; Janmey chromatography on a column of anti-FLAG M2 affinity resins (East-
man Kodak Co.). Myr-ARF1 was expressed in E. coli, which wasand Stossel, 1987; Fukami et al., 1992). Most noteworthy
cotransfected with pBB131, with 0.4 mM IPTG in the presence ofof these, the PI(4,5)P2-regulated actin severing and cap-
0.2 mM myristic acid. Myr-ARF1 in the soluble fraction of the cell wasping protein, gelsolin, has been found by Radhakrishna
purified by chromatography on a ProBond nickel-chelating columnet al. (1996) to colocalize with ARF6 at the ruffles formed
(Invitrogen) using 300 mM imidazole as an elution buffer. After re-
upon AlF4 stimulation and by Steed et al. (1996) to asso- moval of imidazol by dialysis, purified proteins were stored at 2808C
ciate with PLD2. Moreover, Azuma et al. (1998) reported until use.
Recombinant ARF1, RhoA, and Rac1 expressed in Sf9 cells werethat gelsolin-null dermal fibroblasts have a markedly
purified as described previously (Hammond et al., 1997).reduced ruffling response to EGF stimulation. Although
the detailed mechanism by which gelsolin mediates
Preparation of Bovine Brain Cytosolmembrane ruffling formation remains to be clarified, it
Bovine brains were homogenized in 10 mM Tris-HCl (pH 7.5), 1
is presently the best candidate as a target protein for mM EDTA, and 0.1 mM phenylmethylsulfonyl fluoride (PMSF), and
PI(4,5)P2 in this setting. centrifuged at 100,000 3 g for 30 min. The clear supernatant (4 mg/
ml protein) was frozen in liquid nitrogen and stored at 2808C until
use.Experimental Procedures
Purification of the GTPgS-Dependent Activator of PI(4)P5KaReagents and Antibodies
from Bovine Brain CytosolPhospholipids, except for PI(4)P and LPA, were purchased from
Bovine brain cytosol proteins were precipitated with ammoniumAvanti Polar Lipids. PI(4)P, LPA, ATP, and GTPgS were obtained
sulfate at 25%±60% saturation and then dissolved in 20 mM Tris-from Sigma, [g-32P]ATP and [35S]GTPgS from Amersham Life Tech-
HCl (pH 7.5), 1 mM EDTA, 0.1 mM DTT, and 0.1 mM PMSF (buffernologies, and EGF from Takara Shuzo Co., Ltd (Shiga, Japan). Poly-
A). After dialysis against buffer A, the sample was loaded onto aclonal rabbit anti-RhoA, anti-Rac1, and anti-Cdc42 antibodies, and
DEAE Sephacel column and eluted with a linear gradient of 0±0.4a monoclonal mouse anti-myc antibody (9E10) were obtained from
M NaCl in buffer A. PI(4)P5Ka-activating fractions eluted at 0.1 MSanta Cruz Biotechnology. Monoclonal rat anti-HA and mouse anti-
NaCl were concentrated and then subjected to gel filtration chroma-FLAG M2 antibodies were from Boehringer Mannheim and Eastman
tography on a Sephacryl S-300 HR column in buffer B which con-Kodak Co., respectively. Cy3- and FITC-conjugated secondary anti-
sisted of 20 mM Tris-HCl (pH 7.5), 1 mM EDTA, 0.1 mM DTT, 0.1 mMbodies and Alexa 488 phalloidin were from Jackson ImmunoRe-
PMSF, 1 mM GDP, and 50 mM NaCl. PI(4)P5Ka-activating fractionssearch Laboratories and Molecular Probes, respectively. A rabbit
eluted were loaded onto a Hydroxyapatite column, and eluted withanti-ARF antiserum was raised against a synthetic peptide, corre-
a linear gradient of 0±120 mM potassium phosphate (pH 7.5) in 20sponding to amino acid residues 23±36 of ARF1±5 and 19±32 of
mM Tris-HCl (pH 7.5), 0.1 mM DTT, 0.1 mM PMSF, and 1 mM GDP.ARF6. A monoclonal mouse anti-PI(4,5)P2 antibody (AM212) was a
After an equal volume of 4 M ammonium sulfate was added togenerous gift of Dr. Umeda, The Tokyo Metropolitan Institute of
PI(4)P5Ka-activating fractions eluted at 35 mM potassium phos-Medical Science, Japan (Miyazawa et al., 1988).
phate, the fractions were further subjected to chromatography on
a Phenyl-TOYOPEARL 650M column and eluted with a linear gradi-Plasmid Construction
ent of 2±0 M ammonium sulfate. PI(4)P5Ka-activating fractionsPI(4)P5Ka cDNA was amplified from mouse brain total RNA using
eluted at 0.6 M ammonium sulfate were concentrated and gel fil-RT-PCR and the cDNA sequence (Ishihara et al., 1996) verified. The
trated on a Superdex 75 HR 10/30 column with buffer B.mouse ARF cDNAs were previously described (Hosaka et al., 1996).
An N122I mutation was introduced into ARF6 using a PCR-based
Amino Acid Sequence Analysis of the Purifiedstrategy (Toda et al., 1999). pTB701-FLAG and pcDNA3-FLAG were
PI(4)P5Ka Activatorused to construct mammalian expression vectors for N- and C-termi-
The PI(4)P5Ka activator purified from bovine brain cytosol (20 mgnally FLAG epitope±tagged PI(4)P5Ka [FLAG-PI(4)P5Ka] and ARFs
of protein) was digested with 2 mg/ml of trypsin at 378C overnight.(ARFs-FLAG), respectively. pcDNA3-FLAG was constructed by in-
The peptide fragments were separated by reversed-phase HPLC.sertion of the FLAG epitope sequence into pcDNA3 (Invitrogen).
The separated peptides were sequenced by a model PPSQ-21 se-pFLAG-MAC (Eastman Kodak Co.) and pET20b (Novagen) were
quencer (Shimadzu, Kyoto, Japan).used to construct bacterial expression vectors for FLAG-PI(4)P5Ka
and C-terminally 6-His-tagged ARF1 (ARF1-His), respectively. The
bacterial expression vector for N-myristoyltransferase, pBB131, was Assay of PI(4)P5K Activity
PI(4)P5K activity was determined by the incorporation of 32Pi froma generous gift of Dr. Gordon, Washington University (Duronio et
al., 1990). [g-32P]ATP into PI(4)P. In a standard assay, samples containing
PI(4)P5K were incubated at 378C for 25 min in 50 mM Tris-HCl (pHMyc-tagged mammalian expression vectors for PI(4)P5Ka and
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7.5), 1 mM EGTA, 10 mM MgCl2, 0.004% (w/v) NP-40, 50 mM PI(4)P, Berridge, M.J. (1987). Inositol trisphosphate and diacylglycerol: two
interacting second messengers. Annu. Rev. Biochem. 56, 159±193.50 mM [g-32P]ATP (1 mCi/assay), either of 40 mM GTPgS or GDP,
and the indicated concentrations of PA. For purification of a GTPgS- Berridge, M.J., and Irvine, R.F. (1984). Insotisol trisphosphate, a
dependent PI(4)P5Ka activator, recombinant PI(4)P5Ka purified novel second messenger in cellular signal transduction. Nature 312,
from COS-7 cells was reconstituted with each fraction separated by 315±321.
the column chromatographies in the presence of 0.2 M ammonium Billah, M.M. (1993). Phospholipase D and cell signaling. Curr. Opin.
sulfate. After the reaction was terminated by adding chloroform/ Immunol. 5, 114±123.
methanol/11.7 N HCl (200:400:1, by volume), lipids were extracted
Bligh, E.G., and Dyer, W.J. (1959). A rapid method of total lipid
according to the methods of Bligh and Dyer (1959), and separated
extraction and purification. Can. J. Biochem. Physiol. 37, 911±917.
by thin layer chromatography on Merck silica gel 60 plates that were
Boronenkov, I.V., and Anderson, R.A. (1995). The sequence of phos-impregnated with 1.2% potassium oxalate in the solvent system of
phatidylinositol-4-phosphate 5-kinase defines a novel family of lipidchloroform/methanol/acetone/water/acetic acid (7:5:2:2:2, by vol-
kinases. J. Biol. Chem. 270, 2881±2884.ume). The [32P]PI(4,5)P2 produced was analyzed by a BAS2000 Bio-
Brown, H.A., Gutowski, S., Moomaw, C.R., Slaughter, C., andimaging analyzer (Fuji Photo Film, Tokyo, Japan).
Sternweis, P.C. (1993). ADP-ribosylation factor, a small GTP-depen-
dent regulatory protein, stimulates phospholipase D activity. CellConfocal Immunofluorescence Microscopy
75, 1137±1144.HeLa cells grown in Dulbecco's modified Eagles medium (DMEM)
Cantley, L.C., Auger, K.R., Carpenter, C., Duckworth, B., Graziani,supplemented with 5% fetal calf serum (FCS) on glass coverslips
A., Kapeller, R., and Soltoff, S. (1991). Oncogenes and signal trans-were transfected using Lipofectamine Plus (Life Technologies, MD).
duction. Cell 64, 281±302.Transfected cells were treated as described in figure legends, then
fixed, permeabilized, and blocked as previously reported (Torii et Castellino, A.M., Parker, G.J., Boronenkov, I.V., Anderson, R.A., and
al., 1995). To stain PI(4,5)P2 with the anti-PI(4,5)P2 antibody (AM212), Chao, M.V. (1997). A novel interaction between the juxtamembrane
0.01% Triton-X 100 was employed for permeabilization. The cells region of the p55 tumor necrosis factor receptor and phosphatidyl-
were then incubated with monoclonal anti-myc (9E10), anti-HA anti- inositol-4-phosphate 5-kinase. J. Biol. Chem. 272, 5861±5870.
bodies, and anti-PI(4,5)P2 antibodies, followed by fluorescent stain- Chong, L.D., Traynor-Kaplan, A., Bokoch, G.M., and Schwartz, M.A.
ing with FITC- and Cy3-labeled secondary antibodies and Alexa 488 (1994). The small GTP-binding protein Rho regulates a phosphatidyl-
phalloidin. After being washed with PBS, the immunofluorescently inositol 4-phosphate 5-kinase in mammalian cells. Cell 79, 507±513.
stained cells were imaged using a laser-scanning confocal micro- Cochet, C., and Chambaz, E.M. (1986). Catalytic properties of a
scope (TCS4D, Leica Laser Teknik). purified phosphatidylinositol-4-phosphate kinase from rat brain.
Biochem. J. 237, 25±31.
[35S]GTPgS Binding to Recombinant myr-ARF1
Cockcroft, S., Thomas, G.M.H., Fensome, A., Geny, B., Cunningham,
Recombinant myr-ARF1 was incubated for 25 min at 378C with 10
E., Gout, I., Hiles, I., Totty, N.F., Truong, O., and Hsuan, J.J. (1994).
mM [35S]GTPgS in 50 mM Tris-HCl (pH 7.5), 1 mM EGTA, 10 mM
Phospholipase D: a downstream effector of ARF in granulocytes.
MgCl2, 0.004% NP-40, 12.5 mM PI(4)P, and 12.5 mM of the indicated Science 263, 523±526.
phospholipids. After the reaction was terminated by adding 50 mM
Colley, W.C., Sung, T.-C., Roll, R., Jenco, J., Hammond, S.M., Alt-Na-HEPES (pH 7.4), 2.5 mM EDTA, 5 mM MgCl2, and 40 mM GTP,
shuller, Y., Bar-Sagi, D., Morris, A.J., and Frohman, M.A. (1997).samples were transferred to nitrocellulose filters. Filters were
Phospholipase D2, a distinct phospholipase D isoform with novelwashed thoroughly, then the bound [35S]GTPgS was quantified by
regulatory properties that provokes cytoskeletal reorganization.liquid scintillation spectroscopy.
Curr. Biol. 7, 191±201.
Davis, J.N., Rock, C.O., Cheng, M., Watson, J.B., Ashmun, R.A.,Western Blotting
Kirk, H., Kay, R.J., and Roussel, M.F. (1997). Complementation ofWestern blotting experiments were performed as described pre-
growth factor receptor-dependent mitogenic signaling by a trun-viously (Yamazaki et al., 1999) using ECL (Amersham).
cated type I phosphatidylinositol 4-phosphate 5-kinase. Mol. Cell.
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